Stockreport

Keros Therapeutics Appoints Charles Newton to its Board of Directors [Yahoo! Finance]

Lyell Immunopharma, Inc.  (LYEL) 
PDF clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to [Read more]